Stock Events

Stock Events

Search...

Marker Therapeutics (MRKR) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.43

-0.37

-0.31

-0.25

Details

Expected EPS

-0.39

Actual EPS

-0.26

Surprise EPS

0.13

Surprise Percent

+33.33%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.26 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.